Go to the content. | Move to the navigation | Go to the site search | Go to the menu | Contacts | Accessibility

| Create Account

Sella, Stefania (2008) Iperparatiroidismo secondario persistente dopo trapianto di rene: fattori eziopatogenici e possibili correzioni. [Ph.D. thesis]

Full text disponibile come:

[img]
Preview
Documento PDF
674Kb

Abstract (english)

Post-transplantation osteoporosis is influenced by multiple factors. An important risk factor for bone morbidity is rappresented by persistent secondary hyperparathyroidism (PTH >65 pg/ml). From a large cohort of patients who had undergone kidney transplantation, we selected 125 caucasian patients (87 males and 38 females), who had undergone
kidney transplantation 0 to 10 year before, aged 25-65 years, with serum creatinine < 228 ?mol/L. All patients underwent an evaluation of the main biochemical parameters of bone metabolism as well as bone densitometry. In 87 patients we also studied three polymorphism of the Calcium-sensing receptor (A986S, R990G, Q1011E). PTH levels higher than 65 pg/ml were found in 68 % of the patients.
Surprisingly, 40 % of the patients presented 25-OHvitaminD values ? 30 nmol/L (deficiency), 56,8 % values between 30 and 80 nmol/L (insufficiency) and only 3,2 % values >80 nmol/L (normal range). The proportion of patients with osteoporosis was 25,6 % at the spine, 7,2 % at total femur and 16,8 % at femoral neck. Bone density resulted lower in patients who had been treated with dose of glucocorticoid higher than 6,7 mg/day. As regard to vertebral fractures, we observed
that 57 % of the patients had one or more vertebral fracture. In a logistic regression model only PTH levels were predictors of vertebral fracture. Multiple linear regression demostrated that 25-OH vitamin D levels, cumulative glucocorticoid intake, time on dialysis, age and time since transplantation were significantly predictive of persistent hyperparathyroidism.
As regard to CaSR polymorphism, A986S, R990G, Q1011E were
observed in 35,6 %, 11,5 % and 1,1 % of the patients, respectively.
The study did not demonstrate a significant influence of any of the three genetic variants on PTH levels, bone mass or fractures.
We conclude that osteoporosis and persistent secondary
hyperparathyroidism are common in renal transplant patients.
Low 25-OH vitamin D concentrations may exacerbate secondary
hyperparathyroidism. Treatment with vitamin D could be effective for the prevention of post-transplantation bone loss.


Statistiche Download - Aggiungi a RefWorks
EPrint type:Ph.D. thesis
Tutor:Todesco, Silvano
Supervisor:Giannini, Sandro
Ph.D. course:Ciclo 20 > Scuole per il 20simo ciclo > SCIENZE MEDICHE, CLINICHE E SPERIMENTALI > FISIOPATOLOGIA CLINICA
Data di deposito della tesi:2008
Anno di Pubblicazione:2008
Key Words:IPERPARATIROIDISMO, TRAPIANTO, VITAMINA D
Settori scientifico-disciplinari MIUR:Area 06 - Scienze mediche > MED/09 Medicina interna
Struttura di riferimento:Dipartimenti > pre 2012 - Dipartimento di Scienze Mediche e Chirurgiche
Codice ID:824
Depositato il:08 Sep 2008
Simple Metadata
Full Metadata
EndNote Format

Bibliografia

I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. Adams D.H., Neyberger J.M.: Patterns of graft rejection following liver transplantation, J. Hepatol., 1990, 10: 113- 119. Cerca con Google

2. Adams D.H., Pansford S., Gunson B. et al.: Neurological complications following liver transplantation, Lancet, 1987, 1: 949-951. Cerca con Google

3. Aguilar J.I., Radick J., Kodali V., Levis S., Altman R., Sadowsky J.A., Reddy K.R., Jeffers L.J., Parker T., Schill E.R.: Bone disease and plasma vitamin K levels in PBC patients, (abs), Gastroenterology, 1993, 104: A 868. Cerca con Google

4. Alem Am, Sherrad DJ et al: Increased risk oh hip fracture among patients with end- renal disease, Kidney Int, 2000, 58:396-399. Cerca con Google

5. Almawi W.Y., Lipman M.I., Stevens A.C., Zanker B., Hado E.T., Strom T.B.: Abrogation of glucocorticoid mediated inhibition of T cell proliferation by the synergistic action of IL 1 and IL 6 and INF y, J. Immunol., 1991, 146: 3526-3527. Cerca con Google

6. Almond M., J.Kwan, K.Ewans, J.Cunningham: Loss of Bone Mineral Density in the First 12 Months following Renal Transplantation, Nephron, 1994, 66: 52-57. Cerca con Google

7. Argao E.A., Balistreri W.F., Hollis B.W., Ryckman F.C. Effects of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis, Hepatology, 1994, 20: 598-603. Cerca con Google

8. Arnold J.C., Hauser D., Ziegler R., Kommerell B., Otto G., Theilmann L., Wuster C.: Bone disease after liver transplantation, Transplant. Proc., 1992, 24: 2709-2710. Cerca con Google

9. Aschendorf C., Offner G., Winlcler L., Schirg E., Hoyer P.F., Brodehl J.: Adult height achieved in children after kidney transplantation, Am. J. Dis. Child., 1990, 144: 1138-1141. Cerca con Google

10. Atzumi K, Kushida K, Shimizu et al: Risk factor for vertebral fractures in renal osteodystrophy, Ann J.Kidney Dis, 1999,33: 287-297. Cerca con Google

11. Ball AM, Gillen DL, Sherrard D et al: Risk of hip fracture among dyalisis and renal transplant recipient, JAMA, 2002, 288: 3014-3018. Cerca con Google

12. Bateman A., Singh A., Kral T., Solomon S.: The immune hypothalamic pituitary adrenal axis, Endocrinol. Rev., 1989, 10: 92- 112. Cerca con Google

13. Bengoa J.M., Sitrin M.D., Meredith S., Kelly S.E., Shah N., Baker A.L., Rosenberg I.H.: Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease, Hepatology, 1984, 4: 261-265. Cerca con Google

14. Bird G., Friend P., Donaldson J. et al.: Hyperacute rejection in liver transplantation; A case report, Transplant. Proc., 1989, 21: 3742-3744. Cerca con Google

15. Boelaert J, Fenves AZ, Coburns JW: Defoxamine therapy and mucormyosis in dialisis patients: Report of an International registry. Am J Kidney Dis 18: 600-667, 1991 Cerca con Google

16. Bollerslev J., Wilson S.G. et al.: Calcium-sensing receptor gene polymorphism A986S does not predict serum calcium level, bone mineral density, calcaneal ultrasound indices, or fracture rate in a large cohort of elderlt women, Calcif Tissue Int, 2004, 74: 12-17. Cerca con Google

17. Brinner V., J.Landrnann, F.Brunner, G.Thiel: Cyclosporin AInduced Transient Rise in Plasma Alkaline phosphatase in Kidney Transplant Patients, Transplantation, 1993, No 6, 99- 107. Cerca con Google

18. Brinner V., G.Thiel, M.C.Monier-Faugere, B.Bognar, J.Landmann, V.Kamber, H.Malluche: Prevention Of Cancellous Bone Loss But Persistence Of Renal Bone Disease Despite Normal 1,25 Vitamin D Levels Two Years After Kidney Transplantation,Transplantation, 1995 Cerca con Google

19. Broadus A.E.: Physiologic functions of calcium, magnesium and phosphorus, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, first edition published by the American Society for Bone and Mineral Research Society Office, Favus M.J. (ed), Kelseyville, California, 1990, 7: 29-30. Cerca con Google

20. Brown E.M.: Physiology and pathophysiology of the extracellular calcium-sensing-receptor, Am J Med, 1999, 106: 238-253. Cerca con Google

21. Brown E.M., Gamba G., Riccardi D et al.: Cloning and characterization of an extracellular Ca-sensing receptor from bovine parathyroid, Nature, 1993, 366: 575-580. Cerca con Google

22. Buckley L, E.Leib, K.Cartularo, P.Vaceck, S.Cooper: Effects Of Low Dose Corticosteroids On The Bone Mineral Density Of patients With Reumatoid Arthritis, J Bone Mineral Res , 1994, Vol.10 N° 3. Cerca con Google

23. Campistol J, Munoz-Gomez J, Sole M, et al :Results of renal transplantation for dialysis arthropathy, Nephrol Dial Transpl 1990, 4 :492. Cerca con Google

24. Canalis E., Effect of Insulin Growth Factor 1 on DNA and protein synthesis in cultured rat calvaria, J. Clin. Invest., 1980, 66: 709-719. Cerca con Google

25. Canalis E., Lorenzo J., Burgess W.H., Maciag T.: Effects of endothelial cell growth factor on bone remodelling in vitro, J. Clin. Invest., 1987, 79: 52-58. Cerca con Google

26. Canalis E., McCarthy T., Centrella M.: A bone-derived growth factor isolated from rat calvariae is beta 2 microglobulin, Endocrinology, 1987, 121: 1198-1200. Cerca con Google

27. Canalis E et al.: Isolation and characterization of insulin-like growth-factor 1 (somatomedin C) from cultures of fetal rat calvariae, Endocr, 1988, 122: 22-27. Cerca con Google

28. Canalis E., Delany AM.: Mechanisms of glucocorticoid action in bone, Ann NY Acad Sci, 2002, 966: 73-81. Cerca con Google

29. Canalis E.: Regulation of bone remodelling, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, first edition published by the American Society for Bone and Mineral Research Society Office, Favus M.J. (ed), Kelseyville, Califomia, 1990, 6- 23-25. Cerca con Google

30. Canalis E: Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria, Metabolism, 1981, 30: 950-975. Cerca con Google

31. Centrella M.et al.: Trasforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone, J. Biol. Chem., 1987, 262: 2869-2874. Cerca con Google

32. Cetani F., Borsari S. et al.: Calcium-sensing receptor gene polymorphism in primary hyperparathiroidism, J Endocrinol Invest, 2002, 25:614-619. Cerca con Google

33. Cetani F., Pardi E. et al.: Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in italian postmenopausal women, Eur J Endocrinol, 2003, 148: 603-607. Cerca con Google

34. Chao S., K.Tsai, P.Chieng, P.Lee, C.Lee, S.Lee: Bone Mineral Density Profili in Uremic and Renal Transplant Patients, Transplantation Proceedings, 1994,Vol 26, N° 4: 2009-2011. Cerca con Google

35. Chattopadyay N., Cheng I. et al., Identification and localization of extracellular Ca-sensing receptor in rat intestine, Am J Physiol Gastroint Liver Physiol, 1998, 274: G122-G130. Cerca con Google

36. Clohisy D, Thompson R,: Fractures associated with neuropatic arthropathy in adults who have juvenile onset diabetes . J Bone Surg (Am), 1988, 70-A: 1192-1200 Cerca con Google

37. Cobum J.W., Slalopolsky E.: Vitamin D parathyroid hormone and renal osteodystrophy in The Kidney, Brenner B., Rector F. (eds), Philadelphia, W.B.Saunders, 1986, 1657-1729. Cerca con Google

38. Cockburn I.T., Krupp P.: The risk of neoplasms in patients treated with cyclosporine A, J. Autoimmun., 1989, 2: 723-731. Cerca con Google

39. Cohen A, Sambrook P. Shane E: Management of bone loss after organ transplantation, J Bone Mineral Res, 2004, 19: 1919-1932. Cerca con Google

40. Cole D.E.C., Peltekova V.D et al.: A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations, Lancet, 1998, 353: 112-115. Cerca con Google

41. Colonna J.O., Winston D.J., Brill J.E. et al.: Infectious complications in liver transplantation, Arch. Surg., 1988, 123: 360-364. Cerca con Google

42. Compston J.E.: Metabolic bone disease, in Complications of chronic liver disease, Rector W.G. (ed), St. Louis, Mosby, 1992, 295-316. Cerca con Google

43. Conceicao S.,Willcinson R., Feest T., et al. Hypercalcemia following renal transplantation: Causes and consequenses.Clin Nephrol 16 :235-244,1987 Cerca con Google

44. Consensus development conference: Diagnosis, prophylaxis and treatment of osteoporosis, Am. J. Med., 1993, 94: 646-650. Cerca con Google

45. Cosimi A.B., Cho S.I., Delmonico A.C. et al.: A randomised clinical trial compaIing OKT3 and steroids for treatment of hepatic allograft rejection, Transplantation, 1987, 43: 91-95. Cerca con Google

46. Cuervas-Mons V., Millan I., Gavaler J.S. et al.: Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation, Hepatology, 1986, 6: 922-927. Cerca con Google

47. Cvetkovic M., G.Mann, D.Romeo, X.Liang, Y.Ma, W.Jee, Sol Epstein: The Deleterious Effects of Long - Term Cyclosporine A, Cyclosporine G, And FK506 On Bone Mineral Metabolism In Vivo, Transplantation Vol.1231-1237,No.8. Cerca con Google

48. Dahlback-Sjoberg H., Bjorkhem I., Princen H.M.G.: Selective inhibition of mitochondrial 27-hydroxylation of bile acid intermediates and 25 hydroxylation of vitamin D3 by cyclosporin A, Biochem. J., 1993, 293: 203-206. Cerca con Google

49. D'Alessandro A.,Metzler J., Pirsch J.: Tertiary hyperparathyroidism after renal transplantation: Operative indications,. Surgery, 1989, 106: 1049-1056. Cerca con Google

50. Dalle Carbonare L, Arlot ME., Chavassieux PM et al: Comparison of trabecular microarchitecture and remodeling in glucocorticoid induced osteoporosis and postmenopausal osteoporosis, J Bone Mineral Res, 2001, 16:97-103. Cerca con Google

51. D’Angelo A, Calò L., Giannini S., Carraro G., Bonfante L., Favaro, Antonello A: Parathiroid hormone and bone metabolism in Kidney transplantated patient,. Clinical Nephrology, 2000, 53: 19-22. Cerca con Google

52. Davenport A., Davison M., Newton K., et al. Urinary alluminium excretion following renal transplantation and the effect of pulse steroid therapy, Ann Clin Biochem, 1990, 27 :25- 32. Cerca con Google

53. Davis E.- Neto, V.Jorgetti, M.Soeiro, R.Periera, A.Borelli, L.Ianhez, E.Sabbaga, B.Wwajchemberg, S.Arap: Reversal of Aluminium - Releated Bone Disease after Renal Transplantation, American Journal of Nephrology, 1993 ;13 :12 17. Cerca con Google

54. Deierhoi M., Diethelm A.: Management of hyperparathyroidism following renal transplantation, Transplant Management, 1991, 2 :3-10. Cerca con Google

55. Dempster D.W.: Perspectives: Bone histomorphometry in glucocorticoid-induced osteoporosis, J. Bone Miner. Res., 1989, 4; 137 141. Cerca con Google

56. Diamond T.H.: Metabolic bone disease in Primary biliary cirrhosis, J. Gastroenterol. Hepatol.,1990, 5: 66-81. Cerca con Google

57. Diethelm A.,Edwards R.,Whelchel J.: The natural history and surgical treatment of hypercalcemia before and after renal transplantation,Surg Gynecol Obstet, 1982, 154 :481-490. Cerca con Google

58. Drueke T. ,Lacour B.,Touam M., et al.: Effect of aluminium on hematopoiesis , Kidney Int, 29: 45-48, 1986 Cerca con Google

59. Dummer J.S., Harder A., Poorsattar A. et al: Early infections in kidney, heart and liver tranplant recipients on cyclosporine transplantation, Transplantation, 1983, 36: 259-267. Cerca con Google

60. Eastell R., Dickson R.E., Hodgson S.F., Wiesner R.H., Porayko M.K., Wahne H.W., Cedel S.L., Riggs B.L., Krom R.A.F.: Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cir hosis, Hepatology, 1991, 14: 296-300. Cerca con Google

61. Epstein S., Shane E., Bilezikian J.P.: Organ transplantation and osteoporosis, Curr. Opin. Rheumatol., 1995, 7: 255-261. Cerca con Google

62. Epstein S.: Post-transplantation bone disease: the role of irnmunosoppressive agents and the skeletron, J. Bone Miner. Res., 1996, 11: 1-7. Cerca con Google

63. Fisher L.W., Gehron Robey P.,Tuross N., Otsuka A.,Tepen D.A., Esch F.S., Shimasaki S., Termine J.D.: The Mr 24000 phosphoprotein from developing bone is the NH2-terrninal propeptide of the al chain of type I collagen, J. Biol. Chem., 1987, 262: 13457-13463. Cerca con Google

64. Friday K.E., Howard G.A.: Ethanol inhibits human bone cell proliferation and function in vitro, Metabolism, 1991, 40: 562- 565. Cerca con Google

65. Friedenstein A.J.: Precursor cells of mechanocytes, Int. Rev. Cytol., 1976, 47: 327-359. Cerca con Google

66. Genant H.K., Steiger P., Block J.E. et al.: Quantitative computed tomography: Update 1987, Calcif. Tissue Res., 1987, 41: 179- 186. Cerca con Google

67. Giannini S., D’angelo A., Carraro G. et al, Persistently increate bone tournover and low bone density in long term survivors to kidney transplantation. Clin. Nephrol., 2001, 56: 353-63. Cerca con Google

68. Giannini S., D’angelo A., Nobile M., Carraro G., Pavan S., Crepaldi G.et al: The effect of vitamin D receptor polymorphism on secondary hyperparathyroidism and bone density after renal transplantation, J Bone Mineral Res, 2002, 17 (10): 1768-73. Cerca con Google

69. Giannini S, Sella S, Dalle Carbonare: Osteoporosi nel paziente sottoposto a trapianto d’organo, Riv.It.Ost.Gin, 5: 302-309 Cerca con Google

70. Giannini S., Carraro G., Bonato P., Di Landro D., Plebani M., Bernardi D., Rigotti P., Antonello A., Crepaldi G., Sartori L., D' Angelo A.: Metabolic bone disease in kidney transplantation, (abs), Osteoporosis Int., 1996, 6, suppl. 1: PTu 843, 293. Cerca con Google

71. Goldman RR, Dunn JE, Dunlop DD., Stu9rt FP., Abecassia MM, et al, Increased risk of fracture in patients receiving solid organ transplants, J of Bone Mineral Res, 1999, 14 (3): 456-63. Cerca con Google

72. Gomez AG, Navez DM, Rodriguez GM., andez M, Cannata A JB: Review of the concept of vitamin D “suffifiency and Insufficiency”, Nefrologia, 2003, 23 (suppl. 2): 573-7. Cerca con Google

73. Gorensek M.J.,Carey W.D., Vogt D. et al.: A multivariate analysis of risk factors for Cytomegalovirus infection in liver transplant recipients, Gastroenterology, 1990, 98: 1326-1332. Cerca con Google

74. Gotz W., A.Mundinger, B.Gugel, V.Exner, A. Reichelt, P.Schollmeier:: Missing Impact of Cyclosporine on Osteoporosis in Renal Transplant Recipients, Transplantation Proceedings, Cerca con Google

75. 1994, Vol 26, No.5, :2652-2653. Cerca con Google

76. Gowen M.: Cytokines regulate bone cell function, Rheumatology, 1991, 1: 43-50. Cerca con Google

77. Grey A.B., Stapleton J.P., Evans M.C., Tatuell M.A., Arnes R.W., Reld I.R.: The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women, Am. J. Med., 1995, 99: 636- 641. Cerca con Google

78. Grotz W., F.Alexander Mundinger, B.Gugel, V.Exner , G.Kirste, P.Schollmeier,: Bone Fracture And Osteodensitometry With Dual Energy X-Ray Absorptiometry in Kidney Transplant Recipients, Transplantation, 1995,Vol.59, 982-986, No.7 Cerca con Google

79. Haagsma E.B., Thijn C.J.P., Post J.G. et al.: Bone disease after liver transplantation, J. Hepatol., 1988, 6: 94-100. Cerca con Google

80. Hanto D.W., Simmons R.L., Nayarian J.S.: Epstein-Barr virus lymphoproliferative diseases in renal allograft recipients, Heart transplant., 1984, 3: 121-131. Cerca con Google

81. Hauschka P.V., Mavrakos A.E., Iafrati M.D., Doleman S.E., Klagsbrun M.: Growth factors in bone matlix, J. Biol. Chem., 1986, 261: 12665 12674. Cerca con Google

82. Hawkins F.G., Leon M., Lopez M.B., Valero M.A., Larrodera L., Garcia L., Loinaz C., Moreno Gonzales L.: Bone loss and turnover in patients with liver transplantation, Hepatogastroenterology, 1994, 41: 158-161. Cerca con Google

83. Hay J.E., Lindor K.D., Wiesner R.H. et al.: The metabolic bone disease of primary sclerosing cholangitis, Hepatology, 1991, 14: 257-261. Cerca con Google

84. Hay J.E.: Bone disease in cholestatic liver disease, Gastroenterology, 1995, 108: 276-283. Cerca con Google

85. Hay J.E.: Bone disease in liver transplant recipients, Gastroenterol. Clin. N., 1993, 22: 337-349. Cerca con Google

86. Hedlung L., Gallgher J.C.: The effect of age and menopause on bone mineral density of the proximal femur, J. Bone Miner. Res., 1989, 4: 639-42. Cerca con Google

87. Herlong H.F., Becker R.R., Maddrey W.C.: Bone disease in primary biliary cirrhosis: histologic features and response to 25- hydroxyvitamin D, Gastroenterology, 1982, 83: 103-108. Cerca con Google

88. Hock J.M., Centrella M., Canalis E.: Insulin-like growth factor 1 (IGF 1) has indipendent effects on bone matIix formation and cell replication, Endocrinology, 1988, 122: 254-260. Cerca con Google

89. Horber F.F., Casez J.P., Steiger U., Czerniack A., Montandon A., Jaeger P.H.: Changes in bone mass early after kidney transplantation, J. Bone Miner. Res., 1994, 9: 1-9. Cerca con Google

90. House R.M., Dubovsky S.L., Penn I.: Psychiatric aspects of hepatic transplantation, Transplantation, 1983, 36: 146-150. Cerca con Google

91. Jadoul M, Noel H, Van Ypserle: B 2-microglobuline amyloidosis in a patient treated esclusevely by continous ambulatory peritoneal dialisys, Am J Kidnel Dis, 1990,15 :86-88, Cerca con Google

92. Jadoul M, Malgheim J, Prison Y, et al :Effect of renal transplantation on the radiological signs of dialysis amyloid osteoartropathy, Clin Nephrol, 1989,32 :194 197 Cerca con Google

93. Jahn B, Betz M, Deppisch R ,et al :Stirnulation of B 2 microglobuline synthesis in lymphocites after exposure to Cuprophane dyalizer membranes,. Kidney Int, 1991, 40 :285 290. Cerca con Google

94. Janes C., Dickson E.R., Bonde S., Riggs B. L.: Bilirubin inhibits proliferation in cultured normal human osteoblast-like cells: a possible mechanism for bone loss in priInary biliary cirrhosis, (abs), Gastroenterology, 1992, 102: A 827. Cerca con Google

95. Janes C., Dickson E.R., Bonde S., McDonagh A., Riggs B.: Hyperbilirubinemia inhibits osteoblast proliferation: role of bilirubin in the development of cholestatic osteoporosis, (abs), Gastroenterology, 1993, 104: A 922. Cerca con Google

96. Jilka R.L., Hanghoc G., Girasole G., Passeri G., Williams D., Abrams J., Boyce R., Broxmeyer H., Manolagas S.C.: Increased osteoblast development after estrogen loss: mediation by interleukin 6, Science, 1992, 251: 88-91. Cerca con Google

97. Julian B., L.Quarles, K.Niemann: Musculoskeletal Complications Afer Renal Transplantation: Pathogenesis and Treatment, American Juornal of Kidney Diseases, 1992, Vol.l9,No.2 Cerca con Google

98. Julian B.A., Laskow D.A., Dubovsly J., Dubovsky E.V., Curtis J.J., Quarles L.D.: Rapid loss of vertebral bone density after renal transplantation, N. Engl. J Med., 1991, 325: 544-550. Cerca con Google

99. Kahan B.D.: Cyclosporine, N. Engl. J. Med., 1989, 321: 1725- 1738. Cerca con Google

100. Kalef-Ezra J., A.Karantanas, I.Hatzikonstanhnou, G.Sferopoulos, D.Glaros, K.Siamopoulos,: Bone Mineral Status after Renal Trasplantation Assessment by Noninvasive Techniques, Investigative Radiology, 1994, Vol.29, No.2, 127-133. Cerca con Google

101. Kanis J.A. and the WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report, Osteoporosis Int., 1994, 4: 368-381. Cerca con Google

102. Kaplan M.M., Goldberg M.J., Matloff D.S., Neer R.M., Goodman D.B.P.: Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliar cirrhosis, Gastroenterology, 1981; 81: 681-685. Cerca con Google

103. Katz I.A., Epstein S.: Perspectives: Posttransplantation bone disease, J. Bone Miner. Res., 1992, 7: 123-126. Cerca con Google

104. Katz I.A., Li M., Joffe I., Stein B., Jacobs T., Liang X., Ke H., Jee W., Epstein S.: Influence of age on cyclosporin A induced alteration in bone mineral metabolism in the rat in vivo, J. Bone Miner. Res., 1994, 9: 59 67. Cerca con Google

105. Kelly P.J., Sambrook P.N., Eisman J.A.: Potential protection by cyclosporin against glucocorticoid effects on bone, (letter), Lancet, 1989, 2: 1388. Cerca con Google

106. Konsek J., Clohisy D., Teitelbaum S., Blair H.: Isolated osteoclasts express fimctional macrophage membrane receptors, for mannose or fucose, (abs), J. Bone Miner. Res., 1988, 3: S 98. Cerca con Google

107. Krane S.M.: Calcium, phosphate and magnesium in Intemational Encyclopedia of Pharmacology and Therapeutics, Rasmussen H. (ed), Pergamon Press, London, 1976, 1: 19-59. Cerca con Google

108. Kusne S., Dummer S., Singh N. et al.: Infections after liver transplantation. An analysis of 101 consecutive cases, Medicine, 1988, 67: 132-143. Cerca con Google

109. Laan R, Van Riel, Vande Putte et al: Low dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis, Ann Intern Med, 1993, 119, 963-968. Cerca con Google

110. Lake J.R., Wright T.L.: Liver transplantation for patients with hepatitis B: what have we learned from our results, Hepatology, 1991, 13: 796. Cerca con Google

111. Lomonte C, Antonelli M; Cazzato F,Basile et al: Are low levels of 25-OH vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients, J of Nephrology, 2005, 18: 96-101. Cerca con Google

112. Landman J.O., Hamdy N.A., Pauwels E.K., Papapoulos S.E.: Skeletal metabolism in pahents with osteoporosis after discontinuation of long term treatment with oral pamidronate, J. Clin. Endocrinol. Metab., 1995, 80: 3465-3468. Cerca con Google

113. Leblanc A.D., Schneider V.S., Harlan J.E. et al.: Bone mineral loss and recovery after 17 weeks of bed rest, J. Bone Miner. Res., 1990, 5: 843 850. Cerca con Google

114. Li B., Sehajpal P.K., Khanna A. et al.: Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells; demonstration by usage of a novel competitor DNA construct in the quantitative polymerase chain reaction, J. Exp. Med., 1991, 174: 1259-1262. Cerca con Google

115. Linke R, Hampl H, Lobeck H, et al.: Lysine-specific clevage of B 2-microglobuline in amyloid deposits associated with hemodialisis, . Kidney Int, 1989, 36 :675-681. Cerca con Google

116. Llach F.: Parathyroidectomy in cronic renal failure: Indications, surgical approach and the use of calcitriol,.Kidney Int, ,1990, 38: 62-68. Cerca con Google

117. Lopez M.B., Gonzales Pinto I., Hawkins F.G., Valero M.A., Leon M., Loinaz C., Garcia I., Gomez R.: Effect of liver transplantation and immunosuppressive treatrnent on bone rnineral density, Transplant. Proc., 1992, 24: 3044-3046. Cerca con Google

118. Lorentzon M., Lorentzon R. et al.: Calcium sensing receptor gene polymorphism , circulating calcium concentration and bone mineral density in healthy adolescent girls, Eur J Endocrinol, 2001, 144: 257-261. Cerca con Google

119. Lukert B.P., Raisz L.G.: Glucocorticoid induced osteoporosis: pathogenesis and management, Ann. Intern. Med., 1990, 112: 352-364. Cerca con Google

120. Maalouf MN., Shane e., Osteoporosis following solid organ transplantation, J of Clin Endocrin & Met. 2004. Cerca con Google

121. Macey L, Kana S, Jingushy S, Terek R, Borretos D, Borlander ME: Defects of early fracture-healing in experirnental diabetes: J Bone J Surg (am), 1989, 71-A :722 733. Cerca con Google

122. Maddrey W.C.: Bone disease in patients with primary biliary cirrhosis, Prog. Liver Dis., 1990, 9: 537-554. Cerca con Google

123. Mann G., Jacobs T., Buchinsly F., Armstrong E.C., Li M., Ke H., Ma Y., Jee W., Epstein S.: Interferon-y causes loss of bone volume in vivo and fails to arneliorate cyclosporine A induced osteopenia, Endocrinology, 1994, 135: 1077-1083. Cerca con Google

124. Martin T.,Suva L. .Parathyroid-hormone related protein in hypercalcemia of malignancy. Clin Endocrinol (Oxf) 31 :631- 647.1989 Cerca con Google

125. Massai P., G.Garay, M.Ulla,: Bone Mineral Content in Cyclosporine - Treated Renal Transplant Patients, Transplantation Proceedings, 1994, Vol 26, No 5,: 2646-2648. Cerca con Google

126. Matloff D.S., Kaplan M.M., Neer R.M. et al., Osteoporosis in prirnaIy biliary cirrhosis. Effects of 25-hydroxyvitamin D3 treatment, Gastroenterology, 1982, 83: 97-102. Cerca con Google

127. Mazanec D.J., Grisanti J.M.: Drug-induced osteoporosis, Cleve Clin. J. Med., 1989, 56: 297-303. Cerca con Google

128. Mazzaferro S, Diacinti D, Proietti E, Pisani D et al, Morphometric X.ray absorptiometry in the assessment of vertebral fractures in renal transplant patients, Nephol Dial Transpalnt, 2005. Cerca con Google

129. McCaughan G.W., Feller R.B., Osteoporosis in chronic liver disease: pathogenesis, risk factors and management, Dig. Dis., 1994, 12: 223 231. Cerca con Google

130. McDonald J.A., Dunstan C.R., Dilworth P., Sherbon K., Ross Sheil A.G., Evans R.A., McCaughan G.W.: Bone loss after liver transplantation, Hepatology, 1991, 14: 613-619. Cerca con Google

131. Melton L.J., Eddy D.M., Johnston C.C.Jr.: Screening for osteoporosis, Ann. Intern. Med., 1990, 112. 516-528. Cerca con Google

132. Meys E., Fontanges E., Fourcade N., Thomasson A., Pouyet M., Delmas P.: Bone loss after orthotopic liver transplantation, Am. J. Med., 1994, 97: 445-50. Cerca con Google

133. Miedlich S., Lamesch P. et al.: Frequency of the calciumsensing receptor variant A986S in patients with primary hyperparathioidism, Eur J Endocrinol, 2002, 145: 421-427. Cerca con Google

134. Mitchison H.C., Neuberger J.M.: Medical complications of liver transplantation, Dig. Dis., 1993, 11: 78-101. Cerca con Google

135. Mitlak L., Alpert, C.Delmonico, R.Neer: Parathyroid Function in Normocalcermic Renal Transplant Recipients: Evaluation By Calcium Infusion, Journal of Clinical Endocrinology and Metabolism,. vol.72. Cerca con Google

136. Mo X.Y., Zhang Y.Y. et al.: A986S polymorphism of calciumsensing receptor is not related to bone mineral denity or bone size in premenopausal chinese women, Di Yi jun Da Xue Xue Bao, 2004, 24: 1097-1101,1122. Cerca con Google

137. Movsowitz C., Epstein S., Fallon M., Ismail F., Thomas S.: Cyclosporine A in vivo produces severe osteopenia in the rat: effect of dose and duration of adrninistration, Endocrinology, 1988, 123: 2571 2577. Cerca con Google

138. Movsowitz C., Schlosberg M., Epstein S., Ismail F., Fallon M., Thomas S.: Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone, J. Orthop. Res., 1990, 8: 635-641. Cerca con Google

139. Munoz SJ., Deems R.O., Moritz M.J. et al.: Hyperlipidaemia and obesity after orthotopic liver transplantation, Transplant. Proc., 1991, 23: 1480-1483. Cerca con Google

140. Nacher M., Aubia J., Serrano S. et al., Effect of cyclosporine A on normal h~nan osteoblasts in vitro, Bone and Mineral, 1994, 26: 231 243. Cerca con Google

141. Nan JH, Moon JI, Chung SS et al: Prevalence and risk factors for vertebral fractures in renal transplants, Trans. Proceed, 2000, 1877. Cerca con Google

142. Nalesnik M.A., Makowka L., Starzl T.E.: The diagnosis and treatement of post transplant lymphoproliferative disorders, Curr. Prob. Surg., 1988, 25: 371-472. Cerca con Google

143. National Kidney Foundation (K-DOQI): Clinical practice guidelines for bone metaBOLISM AND DOSEASE, anN j Kidney, 2003., 42 (suppl 3): S7-201. Cerca con Google

144. Nisbeth U., E.Lind, S. Junghall, U.Backmann, B. Fellstroem Fracture Frequency After Kidney Transplantation In NITp, Nord Italia Transplant, Report 1994. Cerca con Google

145. Noel H, Zingraff J, Bardin T, et al :Tissue distribution of dialysis amyloidosis, Clin Nephrol, 1987, 27 :17S-178. Cerca con Google

146. Nordal K., E.Dahl, J.Halse, L.Aksnes, Y.Thomassen, A.Flatmark Aluminium Metabolism and Bone Histology after Kidney Transplantation A One - Year Follow - Up Study, Journal of Clinical Endocrinology and Metabolism, 1994, Vol.74, No.11. Cerca con Google

147. Okazaki R., Riggs B.I., Conover C.A.: Glucocorticoid regulations of insulin-like growth factor binding protein expression in normal human osteoblast-like cells, Endocrinology, 1994, 134: 126-132. Cerca con Google

148. Orcel P., Bielakoff J., Modrowski D. et al.: Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone, J. Bone Miner. Res., 1989, 4: 387-391. Cerca con Google

149. Orcel P., Denne M.A., De Vemejoul M.C.: Cyclosporin A in vitro decreases bone resorption, osteoclast formation and fusion of cells of the monocyte-macrophage lineage, Endocrinology, 1991, 128: 1638 1646. Cerca con Google

150. Passeri G., Bellido T., Girasole G., Tkaczyk A., Manolagas S.C., Jilka R.L.: Trasforming growth factor beta (TGF _) and interleukin 1 (IL 1) induce the interleukin 11 (IL 11) mRNA in both bone-marrow-derived stromal cells and osteoblasts from humans, (abs), J. Bone Miner. Res., 1993, 8, suppl. 1: S 163. Cerca con Google

151. Passeri G., Girasole G., Jilka R.L., Manolagas S.C.: Increased IL 6 production by murine bone marrow and bone cells following estrogen withdrawal, Endocrinology, 1993, 133: 822-828. Cerca con Google

152. Passeri G., Girasole G., Manolagas S.C., Jilka R.L.: Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells; influence on IL 6 production and osteoclast development, Bone Miner., 1994, 24: 109-126. Cerca con Google

153. Passeri G., Dalle Carbonare L., Giannini S., Musacchio E., Crepaldi G., Sartori L.: Effects of Cyclosporin A on osteoblasts and progenitors from murine bone marrow Osteoporosis Int., 1996. Cerca con Google

154. Paya C.V., Hermans P.E., Washington J.A. et al.: Incidence, distribution and outcome of episodes of infection in 100 orthotopic liver transplantations, Mayo Clin. Proc., 1989, 64: 555-564. Cerca con Google

155. Parfitt A : Are bone problems of dialysis patients always resolved by renal trasplantation ? Zackson CPC series: Cases in metabolic Bone Disease .NY, Education in Practise. 1986 Cerca con Google

156. Pavan S., Giannini S, Sella S., Zordan S et al: Iperparatiroidismo secondario persistente dopo trapianto di rene e ruolo causale dell’ipovitaminosi D,Abstract SIOMMMS, 2005. Cerca con Google

157. Pearce S.H.S., Williamson C. et al.: A familial syndrome of hypocalcemia with hypercalciuria due to mutation in the calcium-sensing receptor, New Engl J Med, 1996, 335: 1115- 1122. Cerca con Google

158. Penn I.: Cancers complication organ transplantation, N. Engl. J. Med., 1990, 323: 1767-1769. Cerca con Google

159. Pichler R., N.Franceschini, B.Young, C.Hugo, T.Andoh, E.Bwrdmann, C.Alpers, W.Bennett, W.Couser, R.Johnson: Pathogenisis of Cyclosporine Nephropathy: Roles of Angiotensin 11 and Osteopontin Bone Mineral Density After Kidney Transplantation Cerca con Google

160. Pietschmann P., A.Vychytil, W.Woloszczuk, J.Kovarik Nephron 1991; 59: 533-536. Bone Metabolism in Patients with Functioning Kidney Grafts: Increased Serum Levels of Osteocalcin and Parathyroid Hormone Despite Normalisation of Kidney Function Cerca con Google

161. Piraino B., Carpenter B., Puschett J: Resolution of hypercalcemia and aluminium bone disease after renal transplantation, Am J Med, 1988, 85: 728-730. Cerca con Google

162. Pollak M.R., Brown E.M. et al.: Mutation in the human calcium -sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, Cell,1993: 1237-1239. Cerca con Google

163. Porayko M.K., Wiesner R.H., Hay J.E., Krom R.A.F., Dickson E.R., Beaver J., Schwerman L.: Bone disease in liver transplant recipients: Incidence, timing and risk factors, Transplant. Proc., 1991, 23: 1462 1465. Cerca con Google

164. Prince R.L., Dick I., Devine A., Price R.I., Guttendge D.H., Ke~ D., Criddle A., Garcia-Webb P., St. John A.: The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 heal~y women aged 35 to 90, J.Bone Miner. Res., 1995, 10: 835-842. Cerca con Google

165. Prummel M.F., Wiersinga W.M., Lips P., Sanders G.T.P., Sauewein H.P.: The course of biochemical parameters of bone turnover during treatment with corticosteroids, J. Clin. Endocrinol. Metab., 1991, 72: 382-386. Cerca con Google

166. Rabinovitz M., Shapiro J., Lian J., Block G.D., Merckel I.S., Van Thiel D.H.: Vitamin D and osteocalcin levels in liver transplant recipients: Is osteocalcin a reliable marker of bone turnover in such cases?, J. Hepatol., 1992, 16: 50-55. Cerca con Google

167. Reinhardt W, Bartelworth H., Wagner K., Heeman UV et al, Sequential changes of biochemical bone parameter after kidney transplantation, Nephrol Dial Tranplat, 1998, 13 436- 42. Cerca con Google

168. Riccardi D., Park J.I., Lee W.S. et al., Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor, Proc Natl Acad Sci, 1995, 92: 131- 135. Cerca con Google

169. Rivas C., Silverberg S.J., Kim T., Shane E.: Osteopenia in cardiac transplant recipients, (abs), J. Bone Miner. Res., 1991, 6, suppl l: T 93. Cerca con Google

170. Saito J., J.Davis, Ds Wasnich, P.Ross,: Users of Low Dose Glucocorticoids Have Increased Bone Loss Rates: A Longitudinal Study, Calcified Tissue International, 1995,57:115- 119. Cerca con Google

171. Sartori L., Boschiero L., Bonato P., Pizzardini M., Giannini S.: Bone loss in kidney-transplanted patients, (abs), J. Bone Miner. Res., 1995, 10, suppl. 1: S 473, 105. Cerca con Google

172. Scillitani A., Garnieri V et al. : Blood ionized calcium is associated with clustered polymorphism in the carboxyl-terminal tail of he calcium sensing receptor, J Clin endocrinol Metab, 2004, 89: 5634-5638. Cerca con Google

173. Scillitani A., Garnieri V et al. : Primary Hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium sensing receptor, J Clin endocrinol Metab, 2007, 92: 277-283. Cerca con Google

174. Searnann E., P.Miach, M.Cooper, J.McKay, J.Dawborn,: The Effect of Renal transplantation on Bone Mass, Transplantation Proceedings, 1989, Vol 21, No l, 2159-2169. Cerca con Google

175. Sherlock S., Dooley J.: Liver transplantation, in Diseases of the liver and biliary system, Blackwell Scientific Publications Limited, Oxford, ed., versione italiana, 1994, 35: 513-528. Cerca con Google

176. Sirchia G., Mascaretti L.: Il trapianto di organi in Italia: organizzazione, attività, prospettive, Notizie Brevi dal Policlinico di Milano, 1996, 1: I VIII. Cerca con Google

177. Sitges-Serra A. Caralps-Riera A: Hyperparathyroidism associated with renal disease. Pathogenesis, natural history, and surgical treatment,. Surg Clin North Am, 67 :359-378 Cerca con Google

178. Slootweg M.C.: Growth hormone and bone, Horm. Metab. Res., 1993, 25: 335-343. Cerca con Google

179. Smith A., Faugre M., Abreo K. Etal.: Aluminium associated bone disease in mild and advanced renal failure: Evidence for high prevalence and morbidity and studies on etiology and diagnosis,. Am J Nephrol, 1986, 6 :275-283, Cerca con Google

180. Stein B., B.Halloran, T. Reinhardt, G.Engstrom, C.Bales, M.Drezner, K.Currie, M.Takizawa, J.Adams, S.Epstein: Cyclosporine A Increased Synthesis of 1,25 Dihydroxyvitamin D3 in the Rat and Mouse, Endocrinology, 1991, Vol l28, No3. Cerca con Google

181. Stewart B.J., Green O.C., Stern P.H.: Cyclosporine A inhibits calcemic hormone-induced bone resoIption in vitro, J. Bone Miner. Res., 1986, 1: 285-291. Cerca con Google

182. Takacs I., Speer G. et al.: Lack of association between calciumsensing receptor gene A986S polymorphism and bone mineral density in Hungarian postmenopausal women, Bone, 2002, 30: 849-852. Cerca con Google

183. Tashjian A.H., Voelker E.F., Lazaro M., Singer F.R., Roberts A.B., Derynck R, Winkler M.E., Levine L.: _ and _ human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria, Proc. Natl. Acad. Sci., USA, 1985, 82: 4535 Cerca con Google

184. Teitelbaum S.L.: Skeletal growth and development, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, American Society for Bone and Mineral Research Society Office, Favus M.J. (ed), Kelseyville, California, 1990, 2: 7-11. Cerca con Google

185. Termine J.D.: Non-collagen proteins in bone, in Cell and Molecular biology of Vertebrate Hard Tissues, Ciba, Foundation Symposium 136, Evered D., Harnett S. (eds), John Wiley and Sons, Chichester, 1988, 178-190. Cerca con Google

186. Todo S., Fung J.J., Tzakis A. et al.: One hundred ten consecutive primary orthotopic liver transplants under FK506 in adults, Transplant. Proc., 1991, 23: 1397-1402. Cerca con Google

187. Torres A, Rodriguez A., Garcia S, Machado M, De Bonis E, Losada M, lorenzo V, Parathyroid function in long term renal transplant patients: importance of pre-tranplant PTH cocncentration, Neprol Dial Transplant, 13 (suppl 3):94-97. Cerca con Google

188. Van Hoek B., Wiesner R.H., Ludwig J., Paya C.: Recurrence of ductopenic rejection in liver allografts afer retransplantation for vanishing bile duct syndrome, Transplant. Proc. 1991, 23: 1442- 1443. Cerca con Google

189. Van Staalen J., E.Sanders, M.Prummel, G.Sanders: Bone Alkaline phosphatase as Indicator of Bone Formation, Clinica Chimica Acta, 1991,201 27-34. Cerca con Google

190. Van Thiel D.H., Dindzans V.J., Gavaler J.S. and Tarter R.E.: The postoperative problems and management of the liver transplant recipient, in Progress in liver diseases, vol. 9, Popper Cerca con Google

191. H., Schaffner F. (eds.), Philadelphia, 1990, 37: 657-685. Cerca con Google

192. Valero M., Loinatz C., L.Larrodera, M.Leon, E.Morreno, F.Hawkins: Calcitonin and Bisphosphonates Treatment in Bone Loss After Liver Transplantation, Calcified Tissue International 1995, 57:1 5-19 Cerca con Google

193. Vautour LM, MeltonLJ 3rd, Clarke BL et al, Long term fracture risk following renal transplantation: a population- based study. Osteoporosis Int, 2004, 15: 160-167. Cerca con Google

194. Vezzoli G., Tanini A. et al.: Influence of calcium sening receptor gene on urinary calcium excretion in stone-former patients, J Am Soc Nephrol, 2002, 13: 2517-2523. Cerca con Google

195. Watson R.G.P., Coulton L., Kanis J.A., Lombard M., Williams R., Neuberger J., Elias E.: Circulating osteocalcin in primary biliary cirrhosis following liver transplantation and during treatment with cyclosporin, J. Hepatol, 1990, 11: 354-358. Cerca con Google

196. Whitfield J.B., Martin N.G.: The effects of inheritance on constituents of plasma: a twin study on some biochemial variables, Ann Clin Biochem, 1984, 21: 176-183. Cerca con Google

197. Withold W., S.Degenhard, M.Heins, B.Garbensee, H.Reinauer Monitoring of Bone Resorption after Renal Transplantation by Measuring the Urinary Excretion of Pyridiurn Cross – Links, Eur J Chem Clin Biochem,1995, 33 :15-21. Cerca con Google

198. Wolpaw T., C.Deal, S. Fleming Brooks, M. Bartucci, J.Schulak, D.Hricik: Factors Influencing Vertebral Bone Density After Renal Transplantation, Transplantation, 1994, Vol.58, 1186- 1189, No.11 Cerca con Google

199. Yamaguchi T., Chattopadhyay N. et al.: Expression of extracellular calcium sensing receptor in human osteoblastic MG-63 cell line, Am J Physiol Cell Physiol, 2001, 280: C382- 393. Cerca con Google

200. Yamauchi M., et al.: Association of polymorphic alleles of the calcium sensing receptor gene with the clinical severity of primary hyperparathyroidism, Clinic Endocrinol, 2001, 55: 373- 379. Cerca con Google

201. Yano S., Sugimoto T. et al.: Association of polymorphic alleles of the calcium sensing receptor gene with parathyroid hormone secretion in hemodialysis patients, Nephron, 85: 317-323. Cerca con Google

202. Zingraff J, Druke T.: Can the nephrologist prevent dialysis releated amyloidosis ? ,Am J Kidney Dis, 1991,18 :1 – 11. Cerca con Google

203. Zingraff J, Noel H, Bardin T. et al : _ 2-microglobuline amyloidosis: A sternoclavicular joint biopsy study in hemodialysis patients, Clin Nephrol, 1990, 33 :94-97. Cerca con Google

204. Zingraff J, Noel H, Bardin T, et al: _ 2-microglobuline amyloidosis as a complication of chronic renal failure: A biopsy proven case, N Engl J Med, 1990, 323 :1070-1071 Cerca con Google

205. Zitelli B.J., Gartner J.C., Malatack J.J. et al.: Pediatric liver tranplantation: Patient evaluation and selection infectious complications and life style after transplantation, Transplant. Proc., 1987, 19: 3309-3316. Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record